Digital communication for NITAGs is no longer optional!

Germany
25 October 2016

In September 2016, STIKO, the German NITAG, launched its own app, the first of its kind in the NITAG community. Anyone can download the app, which is compatible with Android or IOS, and access all STIKO’s recommendations. “This innovative digital project aims to strengthen relationships between healthcare workers and STIKO,” explain Ole Wichmann and Judith Koch from Robert Koch Institute. 

STIKO-App_Screenshot.jpg

Why an application?
STIKO is slightly different from other NITAGs. The committee does not advise the Ministry of Health, but its recommendations are regarded as good medical practice guidelines and help decide if a vaccine will be reimbursed by insurance companies. STIKO recommendations are almost always implemented, but several studies on barriers and enablers to vaccination in Germany showed how important it is to actively engage with physicians. Medical professionals are the key to engaging the population and the main drivers to promote vaccination. For the past few years, STIKO has been evaluating opportunities to improve communication with private physicians (where the majority of vaccinations are implemented), and the increasing number of them using tablets and smartphones in their daily work life encouraged us to develop an app.
How did you develop it?
We published a call for tender and the publisher Börm Bruckmeyer, who has experience in developing medical apps, convinced us. Three people from the immunization unit at the Robert Koch Institute got involved, and we also appealed to the IT department to help with the algorithm. Altogether, the whole process took about a year, from design to launch. 
What can be found in this app?
All recommendations issued by STIKO, and published annually in the Epidemiological bulletin of the Robert Koch Institute, are fully reproduced. Instruction leaflets for all vaccines and FAQs for vaccination are also available on the app’s home screen, as well as up-to-date information on supply bottlenecks or new STIKO recommendations and opinion papers.
Why would a NITAG want to communicate its recommendations?
The stakes are high when promoting our recommendations to all healthcare workers. Well informed physicians will be better equipped to talk to their patients and so improve the acceptance of vaccination, which will in turn increase vaccination rates.

6 weeks after the launch, the app has already been downloaded by 11,000 users and has been consulted almost 400,000 times.

 

Related News & Events

  • Germany
    Background paper

    the German NITAG publishes the background paper to the decision to recommend the vaccination with the inactivated herpes zoster subunit vaccine

    12.03.2019

    The STIKO recommends vaccination with the adjuvanted herpes zoster subunit (HZ/su) inactivated vaccine for the prevention of herpes zoster (HZ) and postherpetic neuralgia (PHN) for all people age 60 years and over (standard vaccination).

    Read more
  • Germany

    Vaccination recommendations by STIKO

    09.02.2016

    The national immunization schedule is developed by STIKO, and an updated version is usually published once a year (usually in August) in the Epidemiological Bulletin of the Robert Koch Institute. STIKO has translated the vaccination recommendations endorsed during the 79th and 81st STIKO meetings and which are considered enacted upon their publication on 24 August 2015.
     

    Read more
  • SAGE

    new Interim Recommendations on Vaccination against Ebola Virus Disease from SAGE

    13.05.2019

    Over the last four weeks, the Ebola outbreak in the Eastern Provinces of the Democratic Republic of Congo (DRC) has deteriorated with a large increase in the number of cases1. A major factor in this rise is an increase in critical security incidents that have dramatically affected the ability to identify, follow up and vaccinate contacts successfully. This context challenges the implementation of ring vaccination based on the identification of contacts and contacts of contacts, as recommended by SAGE in April 2017 and confirmed by SAGE during its April 2019 meeting. Further, a potential vaccine shortage may manifest in case the outbreak expands further and/or is prolonged.

    Read more